首页> 外文期刊>Cell Communication and Signaling >Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway
【24h】

Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway

机译:中草药配方黄勤葛根汤通过调节E2F1 / TS途径增强5-氟尿嘧啶的抗肿瘤活性

获取原文
           

摘要

5-Fluorouracil (5-FU) remains the most widely used agent to treat colorectal cancer (CRC). However, its clinical efficacy is currently limited by the development of drug resistance. Traditional Chinese Herbal Medicine (TCM) has been shown to enhance the efficacy of standard anticancer agents. However, there are only a limited number of well-controlled preclinical and clinical studies documenting the potential benefit of TCM. Herein, we screened a series of TCM formulas in in vitro and in vivo animal models to identify biologically active formulas that were effective against CRC. Cell proliferation and clonogenic assays, cell cycle analysis, immunoblot analysis and qRT-PCR were performed to investigate the mechanism(s) of action of the most active formula Huang-Qin-Ge-Gen-Tang (HQGGT) on growth of human CRC cells. In vivo animal models were used to document the antitumor activity of HQGGT alone and HQGGT in combination with 5-FU. We identified HQGGT, which suppressed the in vivo growth of human colon cancer HT-29 xenografts without associated toxicities. HQGGT displayed anti-proliferative activity against a wide range of CRC cell lines. This growth suppression correlated with induction of apoptosis. HQGGT enhanced the cytotoxicity of 5-FU against human 5-FU-resistant cells (H630R1) and mouse colon cancer cells (MC38). Our studies showed that the mechanism of action of this synergism was the result of suppression of thymidylate synthase (TS) expression by HQGGT. We analyzed different batches of HQGGT and observed consistent chemical fingerprints and biological activity. Finally, we show that orally administered HQGGT significantly enhanced the antitumor effect of 5-FU in mice bearing MC38 xenografts. These findings provide support for the potential role of HQGGT as a novel modulator of fluoropyrimidine chemotherapy in the treatment of CRC.
机译:5-氟尿嘧啶(5-FU)仍然是治疗结直肠癌(CRC)的最广泛使用的药物。然而,其临床功效目前受到耐药性发展的限制。中草药(TCM)已被证明可以增强标准抗癌药的功效。但是,只有很少数量的良好控制的临床前和临床研究证明了中药的潜在益处。本文中,我们在体外和体内动物模型中筛选了一系列中药配方,以鉴定对CRC有效的生物活性配方。进行了细胞增殖和克隆形成测定,细胞周期分析,免疫印迹分析和qRT-PCR,以研究活性最强的配方黄秦-锗-Gen-Tang(HQGGT)对人CRC细胞生长的作用机制。 。使用体内动物模型来证明单独的HQGGT和与5-FU组合的HQGGT的抗肿瘤活性。我们确定了HQGGT,它抑制了人类结肠癌HT-29异种移植物的体内生长,而没有相关的毒性。 HQGGT对广泛的CRC细胞系显示出抗增殖活性。这种生长抑制与细胞凋亡的诱导相关。 HQGGT增强了5-FU对人5-FU耐药细胞(H630R1)和小鼠结肠癌细胞(MC38)的细胞毒性。我们的研究表明,这种协同作用的机制是HQGGT抑制胸苷酸合酶(TS)表达的结果。我们分析了不同批次的HQGGT,并观察到一致的化学指纹和生物学活性。最后,我们表明,口服HQGGT可以显着增强5-FU在带有MC38异种移植物的小鼠中的抗肿瘤作用。这些发现为HQGGT作为氟嘧啶化疗的新型调节剂在CRC治疗中的潜在作用提供了支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号